Zobrazeno 1 - 10
of 148
pro vyhledávání: '"M Nanavaty"'
Autor:
Smeet Gala, Christopher Nieset, Mkaya Mwamburi, M Nanavaty, Yair Levy, Lisa J. McGarry, Edward J. Pearson
Publikováno v:
Leukemia Research. 43:1-8
Treatment of newly-diagnosed patients with chronic-phase chronic myeloid leukemia (CP-CML) with tyrosine kinase inhibitors (TKIs) results in near-normal life expectancy. However, CP-CML patients resistant to initial TKIs face a poorer prognosis and s
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 17(7)
Publikováno v:
Value in Health. 18(7)
Publikováno v:
Value in Health. 18(7)
Autor:
Rajguru, Akanksha J.1, Mishra, Ashwani K.1, Bhargava, Rachna1, Sarkar, Siddharth1, Singh Balhara, Yatan Pal1 ypsbalhara@gmail.com
Publikováno v:
Indian Journal of Psychiatry. Jul2024, Vol. 66 Issue 7, p591-602. 25p.
Publikováno v:
International Journal of Fertility & Sterility. Jul-Sep2024, Vol. 18 Issue 3, p286-292. 7p.
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 14(5)
Costs associated with psoriasis present a considerable economic burden. A previously published review was lacking comprehensive data on biologics. Therefore, a systematic literature review was performed to gain a comprehensive understanding of the ec
Publikováno v:
Value in Health. 17(3)
Publikováno v:
Blood. 128:5587-5587
Introduction: Treatment of CLL has advanced tremendously in the past decade with significant extension of life expectancy in patients diagnosed with the disease. Three anti-CD20 monoclonal antibody (mAB) combinations approved for previously untreated
Publikováno v:
Blood. 128:5593-5593
Introduction: Network meta-analyses (NMA) are used commonly to allow formal comparisons between drugs that were not compared head-to-head in a clinical trial through a common comparator. Two main assumptions are made to allow such methodology: a) the